Moreover, overexpression of IL-6 results in over-activated receptor signaling that contributes to the constitutive activation of STAT3 that has been observed in advanced stages of CTCL [26]. The gene discussed is IL6; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.